104-OR: Novel GIP/GLP-1/Glucagon Receptor Agonist LY3437943: A First-in-Human Dose Study in Healthy Subjects
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes
DOI: 10.2337/db21-104-or
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3176697175
